News

C-Suite Interview with Avivagen (VIVXF) CEO Kym Anthony

Health
0 min read

Noble Capital Markets Senior Research Analyst Joe Gomes sits down with Avivagen CEO Kym Anthony for this exclusive interview.

Research, News, and Advanced Market Data on VIVXF


View all C-Suite Interviews

About Avivagen

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com.

Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy